Active Pharmaceutical Ingredients (API) Market in India 2015-2019

インドの原薬(API)市場2015-2019

◆タイトル:Active Pharmaceutical Ingredients (API) Market in India 2015-2019
◆商品コード:IRTNTR5188
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2015年1月14日
◆ページ数:64
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD3,000 ⇒換算¥339,000見積依頼/購入/質問フォーム
Five UserUSD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,500 ⇒換算¥508,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、インドの原薬(API)市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、インドの原薬(API)市場規模及び予測、種類別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

About Active Pharmaceutical Ingredients
Active pharmaceutical ingredients are the active substances that are used in the manufacture of a drug and have a pharmacological effect. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. Active pharmaceutical ingredients may be synthesized either chemically or through biotechnological methods. They are used in a wide range of therapeutic areas such as oncology, respiratory disorders, and rheumatoid arthritis.

TechNavio’s analysts forecast the API market in India to grow at a CAGR of 10.76 percent over the period 2014-2019.

[Covered in this Report]
This report covers the present scenario and the growth prospects of the API market in India during the period 2014-2019. To calculate the market size, the report considers the revenue generated from the sales of API by vendors in the market. The report provides the vendor landscape and a corresponding detailed analysis of the top three vendors in the market. The market segmentation data and analysis is also provided for the following segmentation types: type of production process and area of therapy.
In addition, the report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.
TechNavio’s report, the API Market in India 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts.

[Key Vendors]
• Aurobindo Pharma
• Cipla
• Dr. Reddy’s Laboratories

[Other Prominent Vendors]
• Anuh Pharma
• Alembic Pharmaceuticals
• A. R. Life Sciences
• Atul Bioscience
• Biocon
• Cadila Pharmaceuticals
• Calyx Chemicals & Pharmaceuticals
• CIRON Drugs and Pharmaceuticals
• CTX Life Sciences
• Dishman Pharmaceuticals & Chemicals
• Elder Pharmaceuticals
• Emcure Pharmaceuticals
• FDC
• Glenmark Pharmaceuticals
• Hetero Drugs
• Hikal
• Ind-Swift Laboratories
• Ipca Laboratories
• J. B. Chemicals and Pharmaceuticals
• Laurus Labs
• Lupin
• Mangalam Drugs & Organics
• Mylan Laboratories
• Orchid Chemicals and Pharmaceuticals
• Ranbaxy Laboratories
• Sandoz
• Sequent Scientific
• Shasun Pharmaceuticals
• Sterling Biotech
• Sun Pharmaceutical Industries
• The Piramal Group
• Torrent Pharmaceuticals
• Unichem Laboratories
• Wockhardt

[Market Driver]
• Strong Preference for Generic Drugs
• For a full, detailed list, view our report

[Market Challenge]
• Regulatory Ban
• For a full, detailed list, view our report

[Market Trend]
• Emergence of Africa
• For a full, detailed list, view our report

[Key Questions Answered in this Report]
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【資料の目次】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05.Introduction

06.Market Landscape
06.1 Market Overview

07.API Market in India
07.1 Market Size and Forecast
07.2 Export and Domestic Consumption
07.3 Five Forces Analysis

08.Market Segmentation by Type of Production Process

09.Market Segmentation by Area of Therapy
09.1 API Market in India for Anti-infectives
09.1.1 Market Segmentation by Type
09.2 API Market in India for the Cardiovascular and Hematopoietic System
09.2.1 Market Segmentation by Type
09.3 API Market in India for the Central Nervous System
09.3.1 Market Segmentation by Type
09.4 API Market in India for the Gastro-intestinal and Hepatobiliary System
09.4.1 Market Segmentation by Type
09.5 API Market in India for the Respiratory System
09.5.1 Market Segmentation by Type
09.6 API Market in India for Oncology
09.6.1 Market Segmentation by Type

10.Buying Criteria

11.Market Growth Drivers

12.Drivers and their Impact

13.Market Challenges

14.Impact of Drivers and Challenges

15.Market Trends

16.Trends and their Impact

17.Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.2 Key Vendor Ranking 2014
17.3 Other Prominent Vendors

18.Key Vendor Analysis
18.1 Aurobindo Pharma
18.1.1 Key Facts
18.1.2 Business Overview
18.1.3 Business Segmentation
18.1.4 Geographical Segmentation by Revenue 2014
18.1.5 Business Strategy
18.1.6 Recent Developments
18.1.7 SWOT Analysis
18.2 Cipla
18.2.1 Key Facts
18.2.2 Business Overview
18.2.3 Product Segmentation
18.2.4 Geographical Segmentation by Revenue 2014
18.2.5 Business Strategy
18.2.6 Recent Developments
18.2.7 SWOT Analysis
18.3 Dr. Reddy’s Laboratories
18.3.1 Key Facts
18.3.2 Business Overview
18.3.3 Business Segmentation by Revenue 2014
18.3.4 Business Segmentation by Revenue 2013 and 2014
18.3.5 Geographical Segmentation by Revenue 2014
18.3.6 Business Strategy
18.3.7 Recent Developments
18.3.8 SWOT Analysis

19.Other Reports in this Series

[List of Exhibits]

Exhibit 1: Market Research Methodology
Exhibit 2: API Market in India: Segmentation
Exhibit 3: API Market in India: Segmentation by Type of Production Process
Exhibit 4: API Market in India: Segmentation by Area of Therapy
Exhibit 6: API Market in India 2014-2019 (US$ billion)
Exhibit 7: API Market in India: Export and Domestic Consumption 2014
Exhibit 8: API Market in India: Market Segmentation by Type of Production Process 2014
Exhibit 9: API Market in India: Segmentation by Area of Therapy 2014
Exhibit 10: API Market in India for Anti-infectives: Segmentation by Type 2014
Exhibit 11: API Market in India for the Cardiovascular and Hematopoietic System: Segmentation by Type 2014
Exhibit 12: API Market in India for the Central Nervous System: Segmentation by Type 2014
Exhibit 13: API Market in India for the Gastro-intestinal and Hepatobiliary System: Segmentation by Type 2014
Exhibit 14: API Market in India for the Respiratory System: Segmentation by Type 2014
Exhibit 15: API Market in India for Oncology: Segmentation by Type 2014
Exhibit 16: Small Molecule Drugs: Patent Expiries 2013-2016
Exhibit 17: WHO’s List of Prequalified API for Vendors in India (22nd October, 2014)
Exhibit 18: Biologic Drugs: Patent Expiries 2014-2019 (EU and US)
Exhibit 19: API Market in India: Segmentation by Type of Vendors 2014
Exhibit 20: Aurobindo Pharma: Business Segmentation
Exhibit 21: Aurobindo Pharma: Geographical Segmentation by Revenue 2014
Exhibit 22: Cipla: Product Segmentation
Exhibit 23: Cipla: Geographical Segmentation by Revenue 2014
Exhibit 24: Active Pharmaceutical Ingredients (API) Market in India: Business Segmentation by Revenue 2014
Exhibit 25: Active Pharmaceutical Ingredients (API) Market in India: Business Segmentation by Revenue 2013 and 2014 (US$ billion)
Exhibit 26: Dr. Reddy’s Laboratories: Geographical Segmentation by Revenue 2014



【掲載企業】

Aurobindo Pharma, Cipla, Dr. Reddy's Laboratories , Anuh Pharma, Alembic Pharmaceuticals, A. R. Life Sciences, Atul Bioscience, Biocon, Cadila Pharmaceuticals, Calyx Chemicals & Pharmaceutical, CIRON Drugs and Pharmaceuticals, CTX Life Sciences , DishmanPharmaceuticals & Chemicals, Elder Pharmaceuticals, Emcure Pharmaceuticals, FDC, Glenmark Pharmaceuticals, Hetero Drug, Hikal, Ind-Swift Laboratories, Ipca Laboratories, J. B. Chemicals and Pharmaceuticals, Laurus Labs, Lupin, Mangalam Drugs & Organics,Mylan Laboratories, Orchid Chemicals and Pharmaceuticals, Ranbaxy Laboratories, Sandoz, Sequent Scientific, Shasun Pharmaceuticals, Sterling Biotech, Sun Pharmaceutical Industries, The Piramal Group, Torrent Pharmaceuticals, Unichem Laboratories, Wockhardt

【資料のキーワード】

原薬(API)、インド、治療、製薬、生産プロセス

★調査レポート[インドの原薬(API)市場2015-2019] (Active Pharmaceutical Ingredients (API) Market in India 2015-2019 / IRTNTR5188)販売に関する免責事項
[インドの原薬(API)市場2015-2019] (Active Pharmaceutical Ingredients (API) Market in India 2015-2019 / IRTNTR5188)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆